Identification of a Novel Class of BRD4 Inhibitors by Computational Screening and Binding Simulations
Author:
Affiliation:
1. Department of Applied Chemistry, Delhi Technological University, Delhi 110042, India
2. Drug Discovery Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612-9416, United States
Funder
National Cancer Institute
National Institute of Neurological Disorders and Stroke
National Heart, Lung, and Blood Institute
Department of Biotechnology , Ministry of Science and Technology
Publisher
American Chemical Society (ACS)
Subject
General Chemical Engineering,General Chemistry
Link
http://pubs.acs.org/doi/pdf/10.1021/acsomega.7b00553
Reference53 articles.
1. Epigenetic Pathways and Glioblastoma Treatment: Insights From Signaling Cascades
2. Epigenetics and Human Disease
3. Lysine acetylation and cancer: A proteomics perspective
4. Bromodomains and Their Pharmacological Inhibitors
5. Structure-based virtual screening of novel, high-affinity BRD4 inhibitors
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Novel inhibitors of bromodomain and extra-terminal domain trigger cell death in breast cancer cell lines;Bioorganic & Medicinal Chemistry;2024-10
2. Unveiling Allosteric Regulation and Binding Mechanism of BRD9 through Molecular Dynamics Simulations and Markov Modeling;Molecules;2024-07-25
3. Identification of potent BRD4‐BD1 inhibitors using classical and steered molecular dynamics based free energy analysis;Journal of Cellular Biochemistry;2024-02-05
4. Accounting for Solvation Correlation Effects on the Thermodynamics of Water Networks in Protein Cavities;Journal of Chemical Information and Modeling;2023-03-14
5. Investigation of novel ligand targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery: complete pharmacophore approach;Journal of Biomolecular Structure and Dynamics;2023-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3